instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'CODEINE'? | Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital Malformations.
The rapid increase of opioid-related overdoses and deaths has become a public health concern in the US. Use of prescription opioids in pregnant women has increased; results from teratogenicity studies remain controversial.
... | Transplacental | DrugAdministrationRoute | CC BY | 33847750 | 20,711,790 | 2021-04-01 |
What was the administration route of drug 'HYDROCODONE BITARTRATE'? | Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital Malformations.
The rapid increase of opioid-related overdoses and deaths has become a public health concern in the US. Use of prescription opioids in pregnant women has increased; results from teratogenicity studies remain controversial.
... | Transplacental | DrugAdministrationRoute | CC BY | 33847750 | 20,711,790 | 2021-04-01 |
What was the administration route of drug 'OXYCODONE HYDROCHLORIDE'? | Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital Malformations.
The rapid increase of opioid-related overdoses and deaths has become a public health concern in the US. Use of prescription opioids in pregnant women has increased; results from teratogenicity studies remain controversial.
... | Transplacental | DrugAdministrationRoute | CC BY | 33847750 | 20,711,790 | 2021-04-01 |
What was the administration route of drug 'TRAMADOL'? | Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital Malformations.
The rapid increase of opioid-related overdoses and deaths has become a public health concern in the US. Use of prescription opioids in pregnant women has increased; results from teratogenicity studies remain controversial.
... | Transplacental | DrugAdministrationRoute | CC BY | 33847750 | 20,711,790 | 2021-04-01 |
What was the dosage of drug 'CODEINE'? | Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital Malformations.
The rapid increase of opioid-related overdoses and deaths has become a public health concern in the US. Use of prescription opioids in pregnant women has increased; results from teratogenicity studies remain controversial.
... | UNKNOWN | DrugDosageText | CC BY | 33847750 | 20,711,790 | 2021-04-01 |
What was the dosage of drug 'HYDROCODONE BITARTRATE'? | Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital Malformations.
The rapid increase of opioid-related overdoses and deaths has become a public health concern in the US. Use of prescription opioids in pregnant women has increased; results from teratogenicity studies remain controversial.
... | UNKNOWN | DrugDosageText | CC BY | 33847750 | 20,711,790 | 2021-04-01 |
What was the dosage of drug 'OXYCODONE HYDROCHLORIDE'? | Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital Malformations.
The rapid increase of opioid-related overdoses and deaths has become a public health concern in the US. Use of prescription opioids in pregnant women has increased; results from teratogenicity studies remain controversial.
... | UNKNOWN | DrugDosageText | CC BY | 33847750 | 20,711,790 | 2021-04-01 |
What was the dosage of drug 'TRAMADOL'? | Association of Gestational Opioid Exposure and Risk of Major and Minor Congenital Malformations.
The rapid increase of opioid-related overdoses and deaths has become a public health concern in the US. Use of prescription opioids in pregnant women has increased; results from teratogenicity studies remain controversial.
... | UNKNOWN | DrugDosageText | CC BY | 33847750 | 20,711,790 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood HIV RNA increased'. | MrHAMER yields highly accurate single molecule viral sequences enabling analysis of intra-host evolution.
Technical challenges remain in the sequencing of RNA viruses due to their high intra-host diversity. This bottleneck is particularly pronounced when interrogating long-range co-evolved genetic interactions given th... | ABACAVIR, EFAVIRENZ, LAMIVUDINE, NELFINAVIR, TENOFOVIR DISOPROXIL FUMARATE, ZIDOVUDINE | DrugsGivenReaction | CC BY-NC | 33849057 | 19,709,900 | 2021-07-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pathogen resistance'. | MrHAMER yields highly accurate single molecule viral sequences enabling analysis of intra-host evolution.
Technical challenges remain in the sequencing of RNA viruses due to their high intra-host diversity. This bottleneck is particularly pronounced when interrogating long-range co-evolved genetic interactions given th... | ABACAVIR, EFAVIRENZ, LAMIVUDINE, NELFINAVIR, TENOFOVIR DISOPROXIL FUMARATE, ZIDOVUDINE | DrugsGivenReaction | CC BY-NC | 33849057 | 19,709,900 | 2021-07-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Viral mutation identified'. | MrHAMER yields highly accurate single molecule viral sequences enabling analysis of intra-host evolution.
Technical challenges remain in the sequencing of RNA viruses due to their high intra-host diversity. This bottleneck is particularly pronounced when interrogating long-range co-evolved genetic interactions given th... | ABACAVIR, EFAVIRENZ, LAMIVUDINE, NELFINAVIR, TENOFOVIR DISOPROXIL FUMARATE, ZIDOVUDINE | DrugsGivenReaction | CC BY-NC | 33849057 | 19,709,900 | 2021-07-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Virologic failure'. | MrHAMER yields highly accurate single molecule viral sequences enabling analysis of intra-host evolution.
Technical challenges remain in the sequencing of RNA viruses due to their high intra-host diversity. This bottleneck is particularly pronounced when interrogating long-range co-evolved genetic interactions given th... | ABACAVIR, EFAVIRENZ, LAMIVUDINE, NELFINAVIR, TENOFOVIR DISOPROXIL FUMARATE, ZIDOVUDINE | DrugsGivenReaction | CC BY-NC | 33849057 | 19,709,900 | 2021-07-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Deep vein thrombosis'. | Upper Extremity Deep Vein Thrombosis After Botulinum Toxin Injection: A Case Report.
Botulinum toxin (BoNT) injection is widely used to improve spasticity. However, after the treatment, the patient may experience pain, inflammation, swelling and redness at the injection site. In this case, we addressed deep vein thromb... | ONABOTULINUMTOXINA | DrugsGivenReaction | CC BY-NC | 33849088 | 19,188,014 | 2021-04 |
What was the administration route of drug 'ONABOTULINUMTOXINA'? | Upper Extremity Deep Vein Thrombosis After Botulinum Toxin Injection: A Case Report.
Botulinum toxin (BoNT) injection is widely used to improve spasticity. However, after the treatment, the patient may experience pain, inflammation, swelling and redness at the injection site. In this case, we addressed deep vein thromb... | Intramuscular | DrugAdministrationRoute | CC BY-NC | 33849088 | 19,188,014 | 2021-04 |
What was the dosage of drug 'ONABOTULINUMTOXINA'? | Upper Extremity Deep Vein Thrombosis After Botulinum Toxin Injection: A Case Report.
Botulinum toxin (BoNT) injection is widely used to improve spasticity. However, after the treatment, the patient may experience pain, inflammation, swelling and redness at the injection site. In this case, we addressed deep vein thromb... | 100 UNITS, SINGLE | DrugDosageText | CC BY-NC | 33849088 | 19,188,014 | 2021-04 |
What was the outcome of reaction 'Deep vein thrombosis'? | Upper Extremity Deep Vein Thrombosis After Botulinum Toxin Injection: A Case Report.
Botulinum toxin (BoNT) injection is widely used to improve spasticity. However, after the treatment, the patient may experience pain, inflammation, swelling and redness at the injection site. In this case, we addressed deep vein thromb... | Recovering | ReactionOutcome | CC BY-NC | 33849088 | 19,188,014 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fracture'. | Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study.
BACKGROUND
The purpose of this retrospective study was to evaluate the survival outcomes of pembr... | ENZALUTAMIDE, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33849473 | 19,158,057 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Joint injury'. | Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study.
BACKGROUND
The purpose of this retrospective study was to evaluate the survival outcomes of pembr... | ENZALUTAMIDE, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33849473 | 19,158,057 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skeletal injury'. | Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study.
BACKGROUND
The purpose of this retrospective study was to evaluate the survival outcomes of pembr... | ENZALUTAMIDE, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33849473 | 19,158,057 | 2021-04-13 |
What was the administration route of drug 'PEMBROLIZUMAB'? | Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study.
BACKGROUND
The purpose of this retrospective study was to evaluate the survival outcomes of pembr... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33849473 | 19,158,057 | 2021-04-13 |
What was the dosage of drug 'ENZALUTAMIDE'? | Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study.
BACKGROUND
The purpose of this retrospective study was to evaluate the survival outcomes of pembr... | 160 mg (milligrams). | DrugDosage | CC BY | 33849473 | 19,158,057 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Alcohol interaction'. | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | ATORVASTATIN, CAFFEINE CITRATE, CLOZAPINE, ESOMEPRAZOLE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33849480 | 19,195,216 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Deep vein thrombosis'. | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | ARIPIPRAZOLE, ATORVASTATIN, CLOZAPINE, ESOMEPRAZOLE MAGNESIUM, HEPARIN SODIUM, MEROPENEM, METFORMIN HYDROCHLORIDE, METHYLPREDNISOLONE, OLANZAPINE, PREDNISOLONE | DrugsGivenReaction | CC BY | 33849480 | 19,270,508 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug level increased'. | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | ATORVASTATIN, CAFFEINE CITRATE, CLOZAPINE, ESOMEPRAZOLE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33849480 | 19,195,216 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Food interaction'. | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | ARIPIPRAZOLE, ATORVASTATIN, CLOZAPINE, ESOMEPRAZOLE MAGNESIUM, HEPARIN SODIUM, MEROPENEM, METFORMIN HYDROCHLORIDE, METHYLPREDNISOLONE, OLANZAPINE, PREDNISOLONE | DrugsGivenReaction | CC BY | 33849480 | 19,270,508 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Heparin-induced thrombocytopenia'. | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | ARIPIPRAZOLE, ATORVASTATIN, CLOZAPINE, ESOMEPRAZOLE MAGNESIUM, HEPARIN SODIUM, MEROPENEM, METFORMIN HYDROCHLORIDE, METHYLPREDNISOLONE, OLANZAPINE, PREDNISOLONE | DrugsGivenReaction | CC BY | 33849480 | 19,270,508 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | ATORVASTATIN, CAFFEINE CITRATE, CLOZAPINE, ESOMEPRAZOLE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33849480 | 19,195,216 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal failure'. | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | ATORVASTATIN, CAFFEINE CITRATE, CLOZAPINE, ESOMEPRAZOLE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33849480 | 19,195,216 | 2021-04-13 |
What is the weight of the patient? | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | 142 kg. | Weight | CC BY | 33849480 | 19,306,427 | 2021-04-13 |
What was the administration route of drug 'ARIPIPRAZOLE'? | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | Other | DrugAdministrationRoute | CC BY | 33849480 | 19,270,508 | 2021-04-13 |
What was the administration route of drug 'DIETARY SUPPLEMENT'? | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | Oral | DrugAdministrationRoute | CC BY | 33849480 | 19,250,372 | 2021-04-13 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33849480 | 19,270,508 | 2021-04-13 |
What was the administration route of drug 'PREDNISOLONE'? | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | Oral | DrugAdministrationRoute | CC BY | 33849480 | 19,270,508 | 2021-04-13 |
What was the dosage of drug 'ALCOHOL'? | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | 60 g (grams). | DrugDosage | CC BY | 33849480 | 19,306,427 | 2021-04-13 |
What was the dosage of drug 'CAFFEINE'? | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | CAFFEINE FLUCTUATING BETWEEN 150 AND 450 MG/DAY (BETWEEN TWO AND SIX 250 ML CANS OF RED BULL PER DAY | DrugDosageText | CC BY | 33849480 | 19,287,006 | 2021-04-13 |
What was the dosage of drug 'DIETARY SUPPLEMENT'? | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | 150 AND 450 MG/DAY | DrugDosageText | CC BY | 33849480 | 19,250,372 | 2021-04-13 |
What was the outcome of reaction 'Acute kidney injury'? | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | Recovered | ReactionOutcome | CC BY | 33849480 | 19,270,508 | 2021-04-13 |
What was the outcome of reaction 'Deep vein thrombosis'? | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | Recovering | ReactionOutcome | CC BY | 33849480 | 19,270,508 | 2021-04-13 |
What was the outcome of reaction 'Drug level increased'? | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | Recovering | ReactionOutcome | CC BY | 33849480 | 19,195,216 | 2021-04-13 |
What was the outcome of reaction 'Food interaction'? | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | Recovering | ReactionOutcome | CC BY | 33849480 | 19,270,508 | 2021-04-13 |
What was the outcome of reaction 'Heparin-induced thrombocytopenia'? | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | Recovering | ReactionOutcome | CC BY | 33849480 | 19,270,508 | 2021-04-13 |
What was the outcome of reaction 'Loss of consciousness'? | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | Recovered | ReactionOutcome | CC BY | 33849480 | 19,270,508 | 2021-04-13 |
What was the outcome of reaction 'Renal failure'? | Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.
Caffeine is a known inhibitor of Clozapine metabolism mediated by inhibition of CYP1A2. Hitherto, the effects of caffeine on Clozapine levels have always been modest, as have the clinical manifestations of toxic... | Recovered | ReactionOutcome | CC BY | 33849480 | 19,195,216 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine.
Dopamine supersensitivity psychosis (DSP) frequently arises with long-term antipsychotic treatment and accounts for a significant proportion of treatment-resistant schizophrenia. The mechanism underlying DS... | OLANZAPINE, QUETIAPINE FUMARATE, RISPERIDONE | DrugsGivenReaction | CC BY-NC | 33849886 | 19,950,257 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine.
Dopamine supersensitivity psychosis (DSP) frequently arises with long-term antipsychotic treatment and accounts for a significant proportion of treatment-resistant schizophrenia. The mechanism underlying DS... | OLANZAPINE, QUETIAPINE FUMARATE, RISPERIDONE | DrugsGivenReaction | CC BY-NC | 33849886 | 19,949,878 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysphemia'. | Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine.
Dopamine supersensitivity psychosis (DSP) frequently arises with long-term antipsychotic treatment and accounts for a significant proportion of treatment-resistant schizophrenia. The mechanism underlying DS... | OLANZAPINE, QUETIAPINE FUMARATE, RISPERIDONE | DrugsGivenReaction | CC BY-NC | 33849886 | 19,949,878 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Extrapyramidal disorder'. | Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine.
Dopamine supersensitivity psychosis (DSP) frequently arises with long-term antipsychotic treatment and accounts for a significant proportion of treatment-resistant schizophrenia. The mechanism underlying DS... | OLANZAPINE, QUETIAPINE FUMARATE, RISPERIDONE | DrugsGivenReaction | CC BY-NC | 33849886 | 19,949,878 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oromandibular dystonia'. | Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine.
Dopamine supersensitivity psychosis (DSP) frequently arises with long-term antipsychotic treatment and accounts for a significant proportion of treatment-resistant schizophrenia. The mechanism underlying DS... | OLANZAPINE, QUETIAPINE FUMARATE, RISPERIDONE | DrugsGivenReaction | CC BY-NC | 33849886 | 19,949,878 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Psychotic symptom'. | Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine.
Dopamine supersensitivity psychosis (DSP) frequently arises with long-term antipsychotic treatment and accounts for a significant proportion of treatment-resistant schizophrenia. The mechanism underlying DS... | OLANZAPINE, QUETIAPINE FUMARATE, RISPERIDONE | DrugsGivenReaction | CC BY-NC | 33849886 | 19,949,878 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine.
Dopamine supersensitivity psychosis (DSP) frequently arises with long-term antipsychotic treatment and accounts for a significant proportion of treatment-resistant schizophrenia. The mechanism underlying DS... | OLANZAPINE, QUETIAPINE FUMARATE, RISPERIDONE | DrugsGivenReaction | CC BY-NC | 33849886 | 19,949,878 | 2021-04-13 |
What was the outcome of reaction 'Akathisia'? | Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine.
Dopamine supersensitivity psychosis (DSP) frequently arises with long-term antipsychotic treatment and accounts for a significant proportion of treatment-resistant schizophrenia. The mechanism underlying DS... | Recovering | ReactionOutcome | CC BY-NC | 33849886 | 19,935,064 | 2021-04-13 |
What was the outcome of reaction 'Dysphemia'? | Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine.
Dopamine supersensitivity psychosis (DSP) frequently arises with long-term antipsychotic treatment and accounts for a significant proportion of treatment-resistant schizophrenia. The mechanism underlying DS... | Recovering | ReactionOutcome | CC BY-NC | 33849886 | 19,949,878 | 2021-04-13 |
What was the outcome of reaction 'Extrapyramidal disorder'? | Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine.
Dopamine supersensitivity psychosis (DSP) frequently arises with long-term antipsychotic treatment and accounts for a significant proportion of treatment-resistant schizophrenia. The mechanism underlying DS... | Recovering | ReactionOutcome | CC BY-NC | 33849886 | 19,949,878 | 2021-04-13 |
What was the outcome of reaction 'Oromandibular dystonia'? | Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine.
Dopamine supersensitivity psychosis (DSP) frequently arises with long-term antipsychotic treatment and accounts for a significant proportion of treatment-resistant schizophrenia. The mechanism underlying DS... | Recovering | ReactionOutcome | CC BY-NC | 33849886 | 19,949,878 | 2021-04-13 |
What was the outcome of reaction 'Psychotic symptom'? | Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine.
Dopamine supersensitivity psychosis (DSP) frequently arises with long-term antipsychotic treatment and accounts for a significant proportion of treatment-resistant schizophrenia. The mechanism underlying DS... | Recovering | ReactionOutcome | CC BY-NC | 33849886 | 19,949,878 | 2021-04-13 |
What was the outcome of reaction 'Rebound psychosis'? | Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine.
Dopamine supersensitivity psychosis (DSP) frequently arises with long-term antipsychotic treatment and accounts for a significant proportion of treatment-resistant schizophrenia. The mechanism underlying DS... | Recovering | ReactionOutcome | CC BY-NC | 33849886 | 19,935,064 | 2021-04-13 |
What was the outcome of reaction 'Tardive dyskinesia'? | Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine.
Dopamine supersensitivity psychosis (DSP) frequently arises with long-term antipsychotic treatment and accounts for a significant proportion of treatment-resistant schizophrenia. The mechanism underlying DS... | Recovering | ReactionOutcome | CC BY-NC | 33849886 | 19,935,064 | 2021-04-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study.
Current guidelines for treatment of immune checkpoint inhibitor (ICI)-induced nephritis are not evidence based and may lead to excess corticosteroid exposure. We aimed to com... | ATEZOLIZUMAB, NIVOLUMAB, OMEPRAZOLE | DrugsGivenReaction | CC BY-NC | 33849926 | 19,950,799 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tubulointerstitial nephritis'. | Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study.
Current guidelines for treatment of immune checkpoint inhibitor (ICI)-induced nephritis are not evidence based and may lead to excess corticosteroid exposure. We aimed to com... | ATEZOLIZUMAB, NIVOLUMAB, OMEPRAZOLE | DrugsGivenReaction | CC BY-NC | 33849926 | 19,950,799 | 2021-04 |
What was the dosage of drug 'OMEPRAZOLE'? | Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study.
Current guidelines for treatment of immune checkpoint inhibitor (ICI)-induced nephritis are not evidence based and may lead to excess corticosteroid exposure. We aimed to com... | 20 mg (milligrams). | DrugDosage | CC BY-NC | 33849926 | 19,950,799 | 2021-04 |
What was the outcome of reaction 'Drug interaction'? | Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study.
Current guidelines for treatment of immune checkpoint inhibitor (ICI)-induced nephritis are not evidence based and may lead to excess corticosteroid exposure. We aimed to com... | Recovered | ReactionOutcome | CC BY-NC | 33849926 | 19,950,799 | 2021-04 |
What was the outcome of reaction 'Tubulointerstitial nephritis'? | Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study.
Current guidelines for treatment of immune checkpoint inhibitor (ICI)-induced nephritis are not evidence based and may lead to excess corticosteroid exposure. We aimed to com... | Recovered | ReactionOutcome | CC BY-NC | 33849926 | 19,950,799 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary sepsis'. | Outcomes following I-131 treatment with cumulative dose exceeding or equal to 600 mCi in differentiated thyroid carcinoma patients.
To evaluate treatment outcomes following radioactive iodine (RAI) treatment with a cumulative dose of ≥≥600 mCi in differentiated thyroid carcinoma (DTC) patients, a retrospective review o... | SODIUM IODIDE I-131 | DrugsGivenReaction | CC BY-NC-SA | 33850490 | 19,196,018 | 2021 |
What was the dosage of drug 'SODIUM IODIDE I-131'? | Outcomes following I-131 treatment with cumulative dose exceeding or equal to 600 mCi in differentiated thyroid carcinoma patients.
To evaluate treatment outcomes following radioactive iodine (RAI) treatment with a cumulative dose of ≥≥600 mCi in differentiated thyroid carcinoma (DTC) patients, a retrospective review o... | CUMULATIVE 944.01?236.9MCI | DrugDosageText | CC BY-NC-SA | 33850490 | 19,196,018 | 2021 |
What was the outcome of reaction 'Pulmonary sepsis'? | Outcomes following I-131 treatment with cumulative dose exceeding or equal to 600 mCi in differentiated thyroid carcinoma patients.
To evaluate treatment outcomes following radioactive iodine (RAI) treatment with a cumulative dose of ≥≥600 mCi in differentiated thyroid carcinoma (DTC) patients, a retrospective review o... | Fatal | ReactionOutcome | CC BY-NC-SA | 33850490 | 19,196,018 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Acute Levetiracetam-Induced Thrombocytopenia in an Anticoagulated Immunocompetent Patient.
Levetiracetam (LEV) is a commonly prescribed anti-seizure medication for the prophylaxis and treatment of focal and generalized seizures. However, a few significant LEV-associated adverse effects have been reported in the literat... | APIXABAN, ASPIRIN, ATORVASTATIN, DEXAMETHASONE, HEPARIN SODIUM, LEVETIRACETAM, LORAZEPAM, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, REMDESIVIR, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 33850675 | 19,191,342 | 2021-03-11 |
What was the administration route of drug 'LEVETIRACETAM'? | Acute Levetiracetam-Induced Thrombocytopenia in an Anticoagulated Immunocompetent Patient.
Levetiracetam (LEV) is a commonly prescribed anti-seizure medication for the prophylaxis and treatment of focal and generalized seizures. However, a few significant LEV-associated adverse effects have been reported in the literat... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33850675 | 19,191,342 | 2021-03-11 |
What was the administration route of drug 'PIPERACILLIN SODIUM\TAZOBACTAM SODIUM'? | Acute Levetiracetam-Induced Thrombocytopenia in an Anticoagulated Immunocompetent Patient.
Levetiracetam (LEV) is a commonly prescribed anti-seizure medication for the prophylaxis and treatment of focal and generalized seizures. However, a few significant LEV-associated adverse effects have been reported in the literat... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33850675 | 19,191,342 | 2021-03-11 |
What was the outcome of reaction 'Thrombocytopenia'? | Acute Levetiracetam-Induced Thrombocytopenia in an Anticoagulated Immunocompetent Patient.
Levetiracetam (LEV) is a commonly prescribed anti-seizure medication for the prophylaxis and treatment of focal and generalized seizures. However, a few significant LEV-associated adverse effects have been reported in the literat... | Recovered | ReactionOutcome | CC BY | 33850675 | 19,191,342 | 2021-03-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Diagnosis of primary CNS lymphoma in a HIV patient with multiple ring-enhancing lesions.
Multiple ring-enhancing lesions on brain MRI in an immunocompromised patient are frequently associated with opportunistic infections such as toxoplasmosis. In this report, we describe the case of a patient with HIV/AIDS who was fou... | AMPICILLIN, AZITHROMYCIN, CEFEPIME HYDROCHLORIDE, DEXAMETHASONE, ETHAMBUTOL HYDROCHLORIDE, LEVETIRACETAM, METRONIDAZOLE, RIFABUTIN, VALGANCICLOVIR, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 33850716 | 20,499,889 | 2021 |
What was the administration route of drug 'VALGANCICLOVIR'? | Diagnosis of primary CNS lymphoma in a HIV patient with multiple ring-enhancing lesions.
Multiple ring-enhancing lesions on brain MRI in an immunocompromised patient are frequently associated with opportunistic infections such as toxoplasmosis. In this report, we describe the case of a patient with HIV/AIDS who was fou... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33850716 | 20,499,889 | 2021 |
What was the dosage of drug 'AMPICILLIN'? | Diagnosis of primary CNS lymphoma in a HIV patient with multiple ring-enhancing lesions.
Multiple ring-enhancing lesions on brain MRI in an immunocompromised patient are frequently associated with opportunistic infections such as toxoplasmosis. In this report, we describe the case of a patient with HIV/AIDS who was fou... | UNKNOWN DOSE | DrugDosageText | CC BY-NC-ND | 33850716 | 20,499,889 | 2021 |
What was the dosage of drug 'AZITHROMYCIN'? | Diagnosis of primary CNS lymphoma in a HIV patient with multiple ring-enhancing lesions.
Multiple ring-enhancing lesions on brain MRI in an immunocompromised patient are frequently associated with opportunistic infections such as toxoplasmosis. In this report, we describe the case of a patient with HIV/AIDS who was fou... | UNKNOWN DOSE | DrugDosageText | CC BY-NC-ND | 33850716 | 20,499,889 | 2021 |
What was the dosage of drug 'CEFEPIME HYDROCHLORIDE'? | Diagnosis of primary CNS lymphoma in a HIV patient with multiple ring-enhancing lesions.
Multiple ring-enhancing lesions on brain MRI in an immunocompromised patient are frequently associated with opportunistic infections such as toxoplasmosis. In this report, we describe the case of a patient with HIV/AIDS who was fou... | UNKNOWN DOSE | DrugDosageText | CC BY-NC-ND | 33850716 | 20,499,889 | 2021 |
What was the dosage of drug 'LEVETIRACETAM'? | Diagnosis of primary CNS lymphoma in a HIV patient with multiple ring-enhancing lesions.
Multiple ring-enhancing lesions on brain MRI in an immunocompromised patient are frequently associated with opportunistic infections such as toxoplasmosis. In this report, we describe the case of a patient with HIV/AIDS who was fou... | UNKNOWN DOSE | DrugDosageText | CC BY-NC-ND | 33850716 | 20,499,889 | 2021 |
What was the dosage of drug 'METRONIDAZOLE'? | Diagnosis of primary CNS lymphoma in a HIV patient with multiple ring-enhancing lesions.
Multiple ring-enhancing lesions on brain MRI in an immunocompromised patient are frequently associated with opportunistic infections such as toxoplasmosis. In this report, we describe the case of a patient with HIV/AIDS who was fou... | UNKNOWN DOSE | DrugDosageText | CC BY-NC-ND | 33850716 | 20,499,889 | 2021 |
What was the dosage of drug 'VALGANCICLOVIR'? | Diagnosis of primary CNS lymphoma in a HIV patient with multiple ring-enhancing lesions.
Multiple ring-enhancing lesions on brain MRI in an immunocompromised patient are frequently associated with opportunistic infections such as toxoplasmosis. In this report, we describe the case of a patient with HIV/AIDS who was fou... | UNKNOWN DOSE | DrugDosageText | CC BY-NC-ND | 33850716 | 20,499,889 | 2021 |
What was the dosage of drug 'VANCOMYCIN'? | Diagnosis of primary CNS lymphoma in a HIV patient with multiple ring-enhancing lesions.
Multiple ring-enhancing lesions on brain MRI in an immunocompromised patient are frequently associated with opportunistic infections such as toxoplasmosis. In this report, we describe the case of a patient with HIV/AIDS who was fou... | UNKNOWN DOSE | DrugDosageText | CC BY-NC-ND | 33850716 | 20,499,889 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product use issue'. | Primary cutaneous nocardiosis caused by Nocardia nova with possible Apremilast contribution.
Primary cutaneous nocardiosis accounts for 5-8 % of all nocardiosis cases and represents a diagnostic dilemma among immunocompetent and immunocompromised hosts. Herein, we present a case of a 30-year-old male with history of ps... | APREMILAST, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC-ND | 33850720 | 19,139,880 | 2021 |
What was the administration route of drug 'APREMILAST'? | Primary cutaneous nocardiosis caused by Nocardia nova with possible Apremilast contribution.
Primary cutaneous nocardiosis accounts for 5-8 % of all nocardiosis cases and represents a diagnostic dilemma among immunocompetent and immunocompromised hosts. Herein, we present a case of a 30-year-old male with history of ps... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33850720 | 19,133,111 | 2021 |
What was the administration route of drug 'TRIAMCINOLONE ACETONIDE'? | Primary cutaneous nocardiosis caused by Nocardia nova with possible Apremilast contribution.
Primary cutaneous nocardiosis accounts for 5-8 % of all nocardiosis cases and represents a diagnostic dilemma among immunocompetent and immunocompromised hosts. Herein, we present a case of a 30-year-old male with history of ps... | Intralesional | DrugAdministrationRoute | CC BY-NC-ND | 33850720 | 19,357,014 | 2021 |
What was the dosage of drug 'TRIAMCINOLONE ACETONIDE'? | Primary cutaneous nocardiosis caused by Nocardia nova with possible Apremilast contribution.
Primary cutaneous nocardiosis accounts for 5-8 % of all nocardiosis cases and represents a diagnostic dilemma among immunocompetent and immunocompromised hosts. Herein, we present a case of a 30-year-old male with history of ps... | UNK, INJECTION | DrugDosageText | CC BY-NC-ND | 33850720 | 19,357,014 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Euglycaemic diabetic ketoacidosis'. | Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature.
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a relatively novel class of oral medications for the treatment of type 2 diabetes mellitus (T2DM). Their use has increased recently due to their... | EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33851013 | 20,776,234 | 2021 |
What was the administration route of drug 'EMPAGLIFLOZIN'? | Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature.
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a relatively novel class of oral medications for the treatment of type 2 diabetes mellitus (T2DM). Their use has increased recently due to their... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33851013 | 20,776,234 | 2021 |
What was the dosage of drug 'EMPAGLIFLOZIN'? | Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature.
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a relatively novel class of oral medications for the treatment of type 2 diabetes mellitus (T2DM). Their use has increased recently due to their... | 25 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33851013 | 20,776,234 | 2021 |
What was the dosage of drug 'LINAGLIPTIN'? | Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature.
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a relatively novel class of oral medications for the treatment of type 2 diabetes mellitus (T2DM). Their use has increased recently due to their... | 5 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33851013 | 20,776,234 | 2021 |
What was the dosage of drug 'METFORMIN HYDROCHLORIDE'? | Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature.
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a relatively novel class of oral medications for the treatment of type 2 diabetes mellitus (T2DM). Their use has increased recently due to their... | 500 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33851013 | 20,776,234 | 2021 |
What was the outcome of reaction 'Euglycaemic diabetic ketoacidosis'? | Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature.
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a relatively novel class of oral medications for the treatment of type 2 diabetes mellitus (T2DM). Their use has increased recently due to their... | Recovering | ReactionOutcome | CC BY-NC-ND | 33851013 | 20,776,234 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Euglycaemic diabetic ketoacidosis'. | A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery.
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a novel group of oral hypoglycemic agents with multiple proven beneficial effects. However, their use has been associated with euglycemic diabetic ketoaci... | EMPAGLIFLOZIN, GLIMEPIRIDE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33851014 | 20,787,553 | 2021 |
What was the administration route of drug 'EMPAGLIFLOZIN'? | A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery.
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a novel group of oral hypoglycemic agents with multiple proven beneficial effects. However, their use has been associated with euglycemic diabetic ketoaci... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33851014 | 20,787,553 | 2021 |
What was the dosage of drug 'EMPAGLIFLOZIN'? | A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery.
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a novel group of oral hypoglycemic agents with multiple proven beneficial effects. However, their use has been associated with euglycemic diabetic ketoaci... | 10 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33851014 | 20,787,553 | 2021 |
What was the dosage of drug 'GLIMEPIRIDE'? | A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery.
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a novel group of oral hypoglycemic agents with multiple proven beneficial effects. However, their use has been associated with euglycemic diabetic ketoaci... | 2 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33851014 | 20,787,553 | 2021 |
What was the dosage of drug 'METFORMIN HYDROCHLORIDE'? | A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery.
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a novel group of oral hypoglycemic agents with multiple proven beneficial effects. However, their use has been associated with euglycemic diabetic ketoaci... | 1000 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33851014 | 20,787,553 | 2021 |
What was the outcome of reaction 'Euglycaemic diabetic ketoacidosis'? | A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery.
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a novel group of oral hypoglycemic agents with multiple proven beneficial effects. However, their use has been associated with euglycemic diabetic ketoaci... | Recovered | ReactionOutcome | CC BY-NC-ND | 33851014 | 20,787,553 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Clinical Case Report: Dissociation of Clinical Course of Coexisting Autoimmune Hepatitis and Graves Disease.
Concurrent autoimmune disorders, including autoimmune hepatitis (AIH), with Graves disease have been reported. Glucocorticoids can simultaneously lower thyroid hormone levels and treat AIH. Recurrence of hyperth... | PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 33851017 | 19,194,076 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperglycaemia'. | Clinical Case Report: Dissociation of Clinical Course of Coexisting Autoimmune Hepatitis and Graves Disease.
Concurrent autoimmune disorders, including autoimmune hepatitis (AIH), with Graves disease have been reported. Glucocorticoids can simultaneously lower thyroid hormone levels and treat AIH. Recurrence of hyperth... | PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 33851017 | 19,194,076 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperthyroidism'. | Clinical Case Report: Dissociation of Clinical Course of Coexisting Autoimmune Hepatitis and Graves Disease.
Concurrent autoimmune disorders, including autoimmune hepatitis (AIH), with Graves disease have been reported. Glucocorticoids can simultaneously lower thyroid hormone levels and treat AIH. Recurrence of hyperth... | PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 33851017 | 19,194,076 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Clinical Case Report: Dissociation of Clinical Course of Coexisting Autoimmune Hepatitis and Graves Disease.
Concurrent autoimmune disorders, including autoimmune hepatitis (AIH), with Graves disease have been reported. Glucocorticoids can simultaneously lower thyroid hormone levels and treat AIH. Recurrence of hyperth... | PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 33851017 | 19,194,076 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Acute Kidney Injury Associated With Semaglutide.
Case reports of acute kidney injury in patients taking the glucagon-like peptide 1 (GLP-1) receptor agonists exenatide and liraglutide have been reported. We report 2 patients with chronic kidney disease due to diabetic kidney disease who experienced rapid worsening of k... | AMLODIPINE BESYLATE, CARVEDILOL, HYDROCHLOROTHIAZIDE\LISINOPRIL, SEMAGLUTIDE | DrugsGivenReaction | CC BY-NC-ND | 33851124 | 20,510,354 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Proteinuria'. | Acute Kidney Injury Associated With Semaglutide.
Case reports of acute kidney injury in patients taking the glucagon-like peptide 1 (GLP-1) receptor agonists exenatide and liraglutide have been reported. We report 2 patients with chronic kidney disease due to diabetic kidney disease who experienced rapid worsening of k... | AMLODIPINE BESYLATE, CARVEDILOL, HYDROCHLOROTHIAZIDE\LISINOPRIL, SEMAGLUTIDE | DrugsGivenReaction | CC BY-NC-ND | 33851124 | 20,510,354 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.